Completed
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants
NCT06797375
- Conditions
- Autoimmune Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
- Locations
-
- Nucleus Network Brisbane Brisbane, Queensland, Australia